0RKT fundamentals
RYVU THERAPEUTICS SA PLN0.40 earnings per share and revenue
Company revenue for the same period amounts to 25.00 M PLN despite the estimated figure of 23.00 M PLN. Also watch annual changes over time to get a bigger picture of 0RKT earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Forecast
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
−4.50
−3.00
−1.50
0.00
1.50
Reported
Estimate
Currency: PLN
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Reported
−2.21
—
—
−4.14
—
—
—
—
Estimate
−0.95
−1.97
−4.15
0.17
−3.89
−4.44
−4.28
0.47
Surprise
−131.69%
—
—
−2,522.14%
—
—
—
—
Revenue
Q1 '20
Q1 '21
Q2 '21
Q4 '21
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
26.00 M
52.00 M
78.00 M
104.00 M
Reported
Estimate
Currency: PLN
Q1 '20
Q1 '21
Q2 '21
Q4 '21
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
13.60 M
6.60 M
5.50 M
17.90 M
—
20.32 M
34.20 M
18.30 M
15.00 M
16.30 M
17.70 M
25.40 M
23.00 M
25.00 M
—
—
Estimate
—
—
7.00 M
—
9.30 M
—
100.60 M
16.20 M
14.00 M
16.30 M
17.90 M
24.50 M
21.90 M
23.00 M
27.50 M
—
Surprise
—
—
−21.43%
—
—
—
−66.00%
+12.96%
+7.14%
−0.02%
−1.12%
+3.67%
+5.02%
+8.70%
—
—